Volume 22, Number 10—October 2016
Research
Community- and Healthcare-Associated Clostridium difficile Infections, Finland, 2008−20131
Saara M. Kotila
, Silja Mentula, Jukka Ollgren, Anni Virolainen-Julkunen, and Outi Lyytikäinen
, Silja Mentula, Jukka Ollgren, Anni Virolainen-Julkunen, and Outi Lyytikäinen
Table 2
Thirty-day case-fatality rates for patients with community-associated and healthcare-associated Clostridium difficile infections, by age and sex, Finland, 2008–2013*
| Age, y | Community-associated |
Healthcare-associated |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Female sex |
Male sex |
p value | Female sex |
Male sex |
p value | ||||||||
| CFR, % (no.) | No. episodes | CFR, % (no.) | No. episodes | CFR, % (no.) | No. episodes | CFR, % (no.) | No. episodes | ||||||
| 1–14 | 0.4 (1) | 252 | 0.0 (0) | 248 | 1.0 | 0.8 (1) | 126 | 3.3 (5) | 152 | 0.2 | |||
| 15–44 | 0.1 (1) | 1,551 | 0.1 (1) | 886 | 1.0 | 2.1 (12) | 578 | 3.2 (17) | 533 | 0.3 | |||
| 45–64 | 0.9 (15) | 1,655 | 2.5 (30) | 1,188 | 0.001 | 7.0 (106) | 1,524 | 8.6 (177) | 2,047 | 0.07 | |||
| 65–74 | 2.6 (25) | 950 | 4.0 (30) | 755 | 0.1 | 7.9 (152) | 1,917 | 13.0 (291) | 2,232 | <0.001 | |||
| 75–84 | 4.8 (57) | 1,195 | 6.2 (42) | 680 | 0.2 | 13.3 (574) | 4,325 | 16.5 (518) | 3,140 | <0.001 | |||
| >84 | 10.7 (101) | 944 | 9.7 (33) | 339 | 0.7 | 17.9 (758) | 4,224 | 23.9 (371) | 1,550 | <0.001 | |||
| All | 3.1 (200) | 6,547 | 3.3 (136) | 4,096 | 0.5 | 12.6 (1,603) | 12,694 | 14.3 (1,379) | 9,654 | <0.001 | |||
*Values in parentheses are total no. deaths in category. CFR, case-fatality rate.
1Preliminary results from this study were presented as a poster at the 3rd International Conference on Prevention and Infection Control; June 16−19, 2015; Geneva, Switzerland.
Page created: September 19, 2016
Page updated: September 19, 2016
Page reviewed: September 19, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.